ScinoPharm Taiwan, Ltd. (1789.TW)

TWD 18.7

(-1.32%)

EBITDA Summary of ScinoPharm Taiwan, Ltd.

  • ScinoPharm Taiwan, Ltd.'s latest annual EBITDA in 2023 was 819.15 Million TWD , down -7.5% from previous year.
  • ScinoPharm Taiwan, Ltd.'s latest quarterly EBITDA in 2024 Q2 was 192.6 Million TWD , down -35.05% from previous quarter.
  • ScinoPharm Taiwan, Ltd. reported an annual EBITDA of 885.47 Million TWD in 2022, up 28.24% from previous year.
  • ScinoPharm Taiwan, Ltd. reported an annual EBITDA of 690.49 Million TWD in 2021, down -9.93% from previous year.
  • ScinoPharm Taiwan, Ltd. reported a quarterly EBITDA of 192.6 Million TWD for 2024 Q2, down -35.05% from previous quarter.
  • ScinoPharm Taiwan, Ltd. reported a quarterly EBITDA of 31.83 Million TWD for 2024 Q3, down -83.47% from previous quarter.

Annual EBITDA Chart of ScinoPharm Taiwan, Ltd. (2023 - 2009)

Historical Annual EBITDA of ScinoPharm Taiwan, Ltd. (2023 - 2009)

Year EBITDA EBITDA Growth
2023 819.15 Million TWD -7.5%
2022 885.47 Million TWD 28.24%
2021 690.49 Million TWD -9.93%
2020 766.64 Million TWD 5.07%
2019 729.67 Million TWD -25.27%
2018 964.23 Million TWD -0.82%
2017 984.47 Million TWD -23.78%
2016 1.29 Billion TWD -0.22%
2015 1.23 Billion TWD 20.14%
2014 1.09 Billion TWD -42.2%
2013 1.84 Billion TWD 8.61%
2012 1.73 Billion TWD 14.39%
2011 1.48 Billion TWD -3.07%
2010 1.58 Billion TWD 1.94%
2009 1.51 Billion TWD 0.0%

Peer EBITDA Comparison of ScinoPharm Taiwan, Ltd.

Name EBITDA EBITDA Difference
Grape King Bio Ltd 2.88 Billion TWD 71.606%
Standard Chem & Pharm CO., LTD. 1.57 Billion TWD 48.121%
Maywufa Company Ltd. 239.81 Million TWD -241.579%
Lotus Pharmaceutical Co., Ltd. 6.87 Billion TWD 88.078%
LIWANLI Innovation Co., Ltd. 6.81 Million TWD -11928.693%
YungShin Global Holding Corporation 1.35 Billion TWD 39.651%
PhytoHealth Corporation -20.69 Million TWD 4057.648%
SCI Pharmtech, Inc. 529.61 Million TWD -54.67%
Formosa Laboratories, Inc. 1.16 Billion TWD 29.584%
PharmaEssentia Corporation -671.48 Million TWD 221.991%
Bora Pharmaceuticals Co., LTD. 5.73 Billion TWD 85.715%